Processing of GABABR1 in heterologous expression systems.
Mosbacher
J
J
Novartis Pharma AG, Basel, Switzerland. Johannes.Mosbacher@pharma.novartis.com
Kaupmann
K
K
Schuler
V
V
Ristig
D
D
Struckmeyer
K
K
Pfaff
T
T
Karschin
A
A
Pozza
M F
MF
Bettler
B
B
D000818:Animals; D002460:Cell Line; D003001:Cloning, Molecular; D019204:GTP-Binding Proteins / Q000378:metabolism*; D049452:Green Fluorescent Proteins; D006801:Humans; D007150:Immunohistochemistry; D008164:Luminescent Proteins; D015221:Potassium Channels / Q000378:metabolism; D051381:Rats; D018080:Receptors, GABA-B / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins
D008164:Luminescent Proteins; D015221:Potassium Channels; D018080:Receptors, GABA-B; D011993:Recombinant Fusion Proteins; D049452:Green Fluorescent Proteins; D019204:GTP-Binding Proteins